Expedited Safety Reporting Requirements for HSA Authorised/Notified Clinical Trials
Learn the expedited safety reporting requirements for HSA authorised / notified clinical trials.
This module on the expedited safety reporting requirements for HSA authorised / notified clinical trials covers the following:
Key Definitions
Expedited Safety Reporting Requirements for HSA Authorised or Notified Clinical Trials
Responsibilities of the Sponsor and the Principal Investigator
What, When and How to Submit Expedited Safety Reports to the HSA
Urgent Safety Measures
Version date: 28 Jul 2025
(Click here to download the slide deck [PDF, 671 KB] (opens in new tab))

Note: With effect from 1 Nov 2026,
The Innovation Office and Clinical Trials Branch (IOCTB) will be renamed Investigational Medicines and Non-Clinical Assessments Division (IMNAD).
IOCTB Learn will be renamed Clinical Trials Learn. Previously published slides and videos will retain the former names.
